Parkinson’s News Today

Throughout my late uncle Brandon’s journey with Parkinson’s disease, my family made sure he kept up with his physical therapy. At one point, we started seeing progress. His balance seemed a […]

Neuropacs’ Automated Imaging Differentiation of Parkinsonism (AIDP) software accurately detected brain changes related to Parkinson’s disease across different patient groups, including some who tested negative on standard alpha-synuclein biomarker tests, a […]

When a diagnosis is made, life goes on. You walk out of your doctor’s office in a fog, wondering if this is a nightmare you’re about to wake up from. You […]

AC Immune has been awarded $4 million to extend the first part of an ongoing clinical trial that’s testing ACI-7104, its experimental vaccine targeting alpha-synuclein protein clumping, which is a hallmark […]

Parkinson’s disease takes a lot away from you. And when you are diagnosed with early-onset Parkinson’s, it can steal so much of your future. I feel lucky that nearly 13 years […]

BIA 28-6156, a small-molecule therapy developed by Bial for GBA-related Parkinson’s disease, did not slow disease progression in a Phase 2 clinical trial involving people with mutations in the GBA1 gene, […]